StockClub

CRDF

CRDFCardiff Oncology, Inc.$ --
Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

CRDF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY +60.9%
Operating Income
-8M USD
YoY +37.7%
Net Income
-7M USD
YoY +38.8%
EPS
-0.11$
YoY +56.0%

Revenue

$593,000
FY2024 Q1$205,000
$205,000
Q1
FY2024 Q2$368,000
$368,000
Q2
FY2024 Q3$533,000
$533,000
Q3
FY2024 Q4$684,000
$684,000
Q4
FY2025 Q1$109,000
$109,000
Q1
FY2025 Q2$230,000
$230,000
Q2
FY2025 Q3$350,000
$350,000
Q3
FY2025 Q4$593,000
$593,000
Q4
Actual
$-91,000 (-13.3%)

Net Income

$-45.9M
FY2024 Q1$-10M
$-10M
Q1
FY2024 Q2$-21.8M
$-21.8M
Q2
FY2024 Q3$-33.6M
$-33.6M
Q3
FY2024 Q4$-45.4M
$-45.4M
Q4
FY2025 Q1$-13.4M
$-13.4M
Q1
FY2025 Q2$-27.4M
$-27.4M
Q2
FY2025 Q3$-38.6M
$-38.6M
Q3
FY2025 Q4$-45.9M
$-45.9M
Q4
Actual
$-421,000 (-0.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$366,000
Est:$267,500
FY2020BEAT
$366,000
FY2021BEAT
Actual:$359,000
Est:$218,167
FY2021BEAT
$359,000
FY2022BEAT
Actual:$386,000
Est:$277,250
FY2022BEAT
$386,000
FY2023MISS
Actual:$488,000
Est:$665,000
FY2023MISS
$488,000
FY2024BEAT
Actual:$683,000
Est:$624,500
FY2024BEAT
$683,000
FY2025BEAT
Actual:$593,000
Est:$455,000
FY2025BEAT
$593,000

Analyst Estimates